Vitamin Usage Patterns in the Prevention of Advanced Age-Related Macular Degeneration

Objective To describe micronutrient usage patterns among patients at a tertiary ophthalmic center. Design Cross-sectional clinical case series. Participants Three hundred thirty-two adult patients with a diagnosis of age-related macular degeneration (AMD). Methods Participants were surveyed about mi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ophthalmology (Rochester, Minn.) Minn.), 2008-06, Vol.115 (6), p.1032-1038.e4
Hauptverfasser: Charkoudian, Leon D., MD, Gower, Emily W., PhD, Solomon, Sharon D., MD, Schachat, Andrew P., MD, Bressler, Neil M., MD, Bressler, Susan B., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective To describe micronutrient usage patterns among patients at a tertiary ophthalmic center. Design Cross-sectional clinical case series. Participants Three hundred thirty-two adult patients with a diagnosis of age-related macular degeneration (AMD). Methods Participants were surveyed about micronutrient usage patterns. The treating ophthalmologist recorded AMD severity using the Age-Related Eye Disease Study (AREDS) classification system. Main Outcome Measures Responses to study questionnaire and level of AMD severity. Results Among 332 participants, 309 (93%) were using supplements, among which 174 (52%) supplemented with an AREDS-like formulation. Of these 174, 140 (80%) were considered AREDS supplement candidates based on study guidelines. Applying AREDS supplementation guidelines to the full cohort, 228 (69%) were candidates for supplementation. Only 140 (61%) of these individuals were confirmed to be using the correct formulation and dosage; an additional 13 (6%) used the AREDS formulation but were not using the recommended dosage. Conclusions Among patients receiving care for AMD at a tertiary retinal center, more than one third of those deemed candidates for AREDS-type supplements were not using them or were using an incorrect dose. Furthermore, nearly one fifth of participants who were using high-dose supplements did not have a level of AMD anticipated to benefit from usage. Increased patient education is needed regarding the recommendations of AREDS.
ISSN:0161-6420
1549-4713
DOI:10.1016/j.ophtha.2007.08.003